Found 6 matching trials
A Study Evaluating the Safety and Efficacy of Neuroprotective Peptide CN-105 Peptide in Patients With Acute Supratentorial Intracerebral Hemorrhage
PHASE2Intracerebral hemorrhage (ICH) is a devastating form of cerebrovascular dis...
Location
Beijing Tiantan Hospital
Evaluation of CN-105 in Subject With Acute Supratentorial Intracerebral Hemorrhage
PHASE2Phase 2, randomized, double-blind, placebo controlled study to evaluate the...
Location
National Neuroscience Institute
Modulating ApoE Signalling to Reduce Brain Inflammation, deLirium and postopErative Cognitive Dysfunction
PHASE2This research study will evaluate the effectiveness and estimate the feasib...
Location
Duke University Hospital
A Proof of Concept Study to Evaluate CN-105 in ICH Patients
PHASE2A multicenter, open-label phase 2a trial of CN-105 in patients with suprate...
Location
A.B. Chandler Medical Center-University of Kentucky
Safety Study of CN-105 Neuroprotective Peptide for Intracerebral Hemorrhage
PHASE1This study evaluates the safety, tolerability, and pharmacokinetics (PK) of...
Location
Duke Clinical Research Institute
Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia
PHASE1The purpose of the first part of this study is to determine the safety and ...
Location
Linear Clinical Research Ltd.